Evaluation of efficacy and effectiveness across the pneumococcal conjugate vaccine era
Pneumococcal conjugate vaccines (PCVs) have resulted in a dramatic reduction in vaccine-type disease in both children and adults. Several expanded PCVs have recently been approved and incorporated into immunization programs for children and adults, with numerous additional vaccine formulations in de...
Saved in:
| Main Author: | David C. LaFon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2491855 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preventive Efficacy of Pneumococcal Conjugated Vaccine (Population Aspects)
by: I. N. Protasova, et al.
Published: (2022-01-01) -
Real-World Impact of Pneumococcal Conjugate Vaccines on Vaccine Serotypes and Potential Cross-Reacting Non-Vaccine Serotypes
by: Kevin Apodaca, et al.
Published: (2025-06-01) -
Changes in serotype distribution of <i>Streptococcus pneumonia</i> circulating among children in the Russian Federation after 13-valent pneumococcal conjugate vaccine introduction.
by: S. V. Sidorenko, et al.
Published: (2023-07-01) -
Pneumococcal vaccines in China
by: Shanshan Wang, et al.
Published: (2025-12-01) -
Pneumococcal Polysaccharide Conjugated Vaccines and the Problem of Changing Circulating Serotypes of Pneumococcus
by: N. N. Kostyukova, et al.
Published: (2023-11-01)